We are live on
!
Find out more
AC
Argentiere Capital Portfolio holdings
AUM
$15.4M
1-Year Est. Return
8.82%
This Fund
S&P 500
This Quarter
Est. Return
-0.02%
1 Year Est. Return
-8.82%
3 Year Est. Return
+1.98%
5 Year Est. Return
+9.17%
10 Year Est. Return
–
AUM
$15.4M
AUM Growth
-$215M
(-93%)
Cap. Flow
-$215M
Cap. Flow
% of AUM
-1,396.57%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
39
New
–
Increased
–
Reduced
1
Closed
37
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$7.55M |
| 2 |
RHT
Red Hat Inc
RHT
|
+$5.54M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$4.42M |
| 4 |
AGN
Allergan plc
AGN
|
+$3.81M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$3.73M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 0% |
| 2 | Energy | 0% |
| 3 | Financials | 0% |
| 4 | Healthcare | 0% |
| 5 | Industrials | 0% |
Similar funds
TCM
HCA
DPA
MP
MMPI
AF
KAM
BA
Argentiere Capital's Q2 2019 Portfolio in Review
As of Q2 2019, Argentiere Capital held 39 positions worth $15.4M, down 93% from $230M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Argentiere Capital withdrew a net $215M in Q2 2019, closing 37 positions and reducing 1 holding. Its most notable exit was Celgene Corp, an estimated $7.55M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 0% of assets, down from 2.4% a quarter earlier, followed by Energy and Financials.
- Argentiere Capital fully exited Celgene Corp in Q2 2019, selling an estimated $7.55M.
- Argentiere Capital's ten largest holdings make up 100% of its $15.4M portfolio in Q2 2019.
- Argentiere Capital opened 0 new positions and closed 37 in Q2 2019.
- Argentiere Capital's portfolio value fell 93% quarter-over-quarter to $15.4M.
Based on Argentiere Capital's 13F filing for Q2 2019, filed 14 Aug 2019.